Tuesday 26th April 2016
Drug-induced Raynaud’s phenomenon is ‘probably underestimated'
Raynaud's phenomenon can be triggered or worsened by certain drugs, such as beta blockers. But knowledge about the condition is limited.
Tuesday 26th April 2016
M10 Peptide Shows Anti-Fibrotic Activity in Mice
Researchers recently discovered a natural molecule, the M10 peptide, that can significantly decrease fibrosis in a mouse model of scleroderma.
Tuesday 19th April 2016
Largest scleroderma study to date has created a complete genetic map of the disease
Friday 15th April 2016
How I Manage My Auto Immune Diseases Without Medication
Well! It’s not easy but I have managed it with a few changes over the years to my nutrition and a good exercise plan.
Thursday 14th April 2016
What Exactly is 'Pre-Scleroderma'?
Tuesday 12th April 2016
Endothelin-1 Receptor Blockers Again Shown to Be Ineffective in Treating Skin Fibrosis
Saturday 2nd April 2016
What is research doing for me?
Prof. Denton, Consultant Rheumatologist at the Royal Free Hospital, London opened the World Systemic Sclerosis Congress with a presentation on 'What is research doing for me?' This uplifting and informative presentation highlighted the positive breakthroughs taking place in scleroderma research.
Wednesday 30th March 2016
Halfway Point Marked in Scleroderma Patient Enrolment for Cytori's ECCS-50 Phase 3 Trial
Cytori Therapeutics has enrolled and treated its 40th patient with scleroderma in the Phase 3 STAR clinical trial for ECCS-50, marking 50 percent of target enrollment.